- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
AMO sells monthly contact lenses in Europe, Asia
Santa Ana, CA-Advanced Medical Optics Inc. (AMO) plans to sell its COMPLETE Aquavision monthly contact lenses in Europe and certain Asia Pacific markets through an agreement with CooperVision Limited, a unit of The Cooper Companies.
Santa Ana, CA-Advanced Medical Optics Inc. (AMO) plans to sell its COMPLETE Aquavision monthly contact lenses in Europe and certain Asia Pacific markets through an agreement with CooperVision Limited, a unit of The Cooper Companies.
Under terms of the deal, AMO will have exclusive sales rights to the hydrogel HEMA/GMA contact lens in select markets. AMO will begin marketing the lens along with a compatible multi-purpose solution and a lens-cleaning device in what it will call the COMPLETE Experience in the third quarter of 2004.
